- My Forums
- Tiger Rant
- LSU Recruiting
- SEC Rant
- Saints Talk
- Pelicans Talk
- More Sports Board
- Fantasy Sports
- Golf Board
- Soccer Board
- O-T Lounge
- Tech Board
- Home/Garden Board
- Outdoor Board
- Health/Fitness Board
- Movie/TV Board
- Book Board
- Music Board
- Political Talk
- Money Talk
- Fark Board
- Gaming Board
- Travel Board
- Food/Drink Board
- Ticket Exchange
- TD Help Board
Customize My Forums- View All Forums
- Show Left Links
- Topic Sort Options
- Trending Topics
- Recent Topics
- Active Topics
Started By
Message
Gilead remdesivir study published in NEJM: two third of severe ill patients improved
Posted on 4/10/20 at 7:01 pm
Posted on 4/10/20 at 7:01 pm
quote:
In this cohort of patients hospitalized for severe Covid-19 who were treated with compassionate-use remdesivir, clinical improvement was observed in 36 of 53 patients (68%). Measurement of efficacy will require ongoing randomized, placebo-controlled trials of remdesivir therapy.
LINK
Posted on 4/10/20 at 7:05 pm to Northwestern tiger
The media will call this irresponsible kook science
Posted on 4/10/20 at 7:20 pm to Northwestern tiger
quote:
two third of severe ill patients improved
Where did you get the “severe” part? Are all hospitalized patients in the study considered severe? Or were some moderate but being monitored in the hospital?
I’m not trying to argue with you just trying to analyze this article. Were 2/3rds going to recover with no medical treatment anyway? I wish it was a higher percentage than 68%.
Posted on 4/10/20 at 7:28 pm to Northwestern tiger
Depending on the severity of the patients that’s good news.
Posted on 4/10/20 at 9:02 pm to Northwestern tiger
quote:
remdesivir
This is the key late stage treatment.
The HCQ/Z-pak/Zinc cocktail needs to be earlier - when the case gets serious, but before desat levels get into ventilator areas.
Posted on 4/10/20 at 11:24 pm to Northwestern tiger
Hospitals in New Orleans have been using it in their COVID protocol since mid March.
Posted on 4/11/20 at 12:12 am to Northwestern tiger
It’s a meaningless study without a control group. The only conclusions you can draw from this is some people got remdesivir and some of them got better while others didn’t.
In normal times a paper like this gets rejected in 12 seconds by a journal of such repute.
In normal times a paper like this gets rejected in 12 seconds by a journal of such repute.
Popular
Back to top
Follow TigerDroppings for LSU Football News